No phaseStatus unknown
Comparative Study of Allopurinol and Febuxostat Effects in Hyperuricemia and Chronic Kidney Disease Patients Using Serum Asymmetric Dimethyl Arginine as an Endothelial Dysfunction Marker.
- Sponsor
- Mohamed Eldougdoug
- Enrolment
- 150 planned
- Conditions
- Kidney Disease
- Interventions
- Allopurinol; Febuxostat; Usual care
- Ages
- adults
- Registry
- PACTR202607678798356
Full record on the Pan African Clinical Trials RegistrySource: WHO ICTRP, processed 14 September 2026
Primary outcomes
- Serum uric acid (mg/dL)
- Estimated GFR (mL/min/1.73 m2)
- Serum asymmetric dimethylarginine (µmol /L)
History
Last registry update
Registered
Results first posted
Started